• 3-5 Impasse Reille 75014 Paris France
  • info@depixus.com
Logo
  • About Us
  • Applications
  • Technology
  • Careers
  • News
    • Press Releases
    • Events
    • Webinars
  • Contact

AGBT 2022

  • Home
  • Blog Details
AGBT 2022
  • Wednesday, 11 October at 4:30 p.m. CEST/10:30 a.m. EDT

June 6 – 9, Bonnet Creek, Orlando, FL

Gordon Hamilton, CEO, and Steve Allen, CBO, of Depixus®, will be participating in this pre-eminent genome science and technology conference for top global researchers, leaders andinnovators. The AGBT General Meeting will be taking place in Bonnet Creek, Orlando, USA,between 6 and 9 June 2022.

Depixus® will be discussing its game changing MAGNA technology with leading genomics scientists from both academia and industry.

Previous Post
Depixus® raises EUR 30.6M (USD 35.4M) In Series A financing
Next Post
EACR Conference on Cancer Genomics 2022
Shape
Logo

Depixus® is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNA™ enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies.

Company

  • About us
  • Applications
  • Technology
  • Careers
  • News
  • Contact us

Contact info

  • 3-5 impasse Reille 75014 Paris, France

    +33 9 72 63 28 89
  • General enquiries : info@depixus.com

  • Please visit our Careers Page for jobs and internships.

Connect with Depixus

©2023 Depixus. All rights reserved. Website design by IIH GLOBAL. Terms & Conditions.